Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC
Sign Up to like & getrecommendations! Published in 2017 at "Journal for Immunotherapy of Cancer"
DOI: 10.1186/s40425-017-0274-x
Abstract: BackgroundAdvanced non-small cell lung cancer patients receiving TG4010, a therapeutic viral vaccine encoding human Mucin 1 and interleukin-2 in addition to standard chemotherapy, displayed longer overall survival in comparison to that of patients treated with… read more here.
Keywords: viral based; based vaccine; response; tg4010 ... See more keywords